Stock SYAB SYNLAB AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials SYNLAB AG Deutsche Boerse AG

Equities

SYAB

DE000A2TSL71

Healthcare Facilities & Services

Market Closed - Deutsche Boerse AG
Other stock markets
 09:59:57 2024-04-26 EDT 		5-day change 1st Jan Change
10.42 EUR -0.38% Intraday chart for SYNLAB AG +1.36% -8.68%
04-22 Synlab Faces Cyber Attack in Italy MT
04-21 Dpa-AFX Overview: COMPANIES - The most important news from the weekend DP

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,244 2,510 2,509 2,308 - -
Enterprise Value (EV) 1 6,847 4,085 2,509 3,880 3,919 3,759
P/E ratio 8.39 x 16.6 x 27.2 x 25.6 x 33.9 x -
Yield 1.4% 2.91% - 0.86% 2.1% 3.14%
Capitalization / Revenue 1.39 x 0.77 x 0.95 x 0.79 x 0.74 x 0.7 x
EV / Revenue 1.82 x 1.26 x 0.95 x 1.33 x 1.26 x 1.13 x
EV / EBITDA 5.66 x 5.43 x 5.73 x 6.98 x 6.38 x 5.11 x
EV / FCF 7.89 x 8.67 x - 40.7 x 30.1 x -
FCF Yield 12.7% 11.5% - 2.46% 3.32% -
Price to Book 2.32 x 1.07 x - 0.97 x 0.89 x 0.8 x
Nbr of stocks (in thousands) 222,222 221,562 219,707 219,775 - -
Reference price 2 23.60 11.33 11.42 10.50 10.50 10.50
Announcement Date 22-03-16 23-03-16 24-03-25 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 3,765 3,251 2,635 2,914 3,102 3,314
EBITDA 1 - 1,210 753 437.9 556 614 735
EBIT 1 - 996.1 508 194.2 351 410 437
Operating Margin - 26.46% 15.63% 7.37% 12.05% 13.22% 13.19%
Earnings before Tax (EBT) 1 - 805.6 283 143 273 329 -
Net income 1 257.6 624.8 151 92.27 91.4 69.2 253
Net margin - 16.6% 4.64% 3.5% 3.14% 2.23% 7.63%
EPS 2 - 2.811 0.6815 0.4200 0.4100 0.3100 -
Free Cash Flow 1 - 867.2 471.4 - 95.3 130.2 -
FCF margin - 23.03% 14.5% - 3.27% 4.2% -
FCF Conversion (EBITDA) - 71.68% 62.6% - 17.14% 21.21% -
FCF Conversion (Net income) - 138.8% 312.15% - 104.27% 188.15% -
Dividend per Share 2 - 0.3300 0.3300 - 0.0900 0.2200 0.3300
Announcement Date 21-04-20 22-03-16 23-03-16 24-03-25 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2023 Q1 2023 Q2
Net sales 1 992.6 1,061 790.4 1,851 697.9 702.4 669.7
EBITDA 1 - 356.9 171.1 528 135 118.5 113.5
EBIT - 300.1 110.7 410.8 75.8 60.5 -
Operating Margin - 28.28% 14% 22.19% 10.86% 8.61% -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 22-03-16 22-05-12 22-08-11 22-08-11 22-11-10 23-05-12 23-08-09
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 1,602 1,575 - 1,572 1,611 1,451
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 1.324 x 2.092 x - 2.827 x 2.624 x 1.974 x
Free Cash Flow 1 - 867 471 - 95.3 130 -
ROE (net income / shareholders' equity) - 39% 14.9% - 3.9% 2.9% -
ROA (Net income/ Total Assets) - 12.6% 6.33% - - - -
Assets 1 - 4,949 2,386 - - - -
Book Value Per Share 2 - 10.20 10.60 - 10.80 11.70 13.20
Cash Flow per Share 2 - 4.700 2.840 - 1.560 1.640 1.790
Capex 1 - 144 158 - 277 279 -
Capex / Sales - 3.84% 4.87% - 9.5% 8.99% -
Announcement Date 21-04-20 22-03-16 23-03-16 24-03-25 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for SYNLAB AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.5 EUR
Average target price
14.5 EUR
Spread / Average Target
+38.10%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.57B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-15.34% 1.03B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. SYAB Stock
  4. SYAB Stock
  5. Financials SYNLAB AG